Awarded in 2008 and completed in 2011, this study generated new knowledge on virus-induced cancers, publishing in Virology and the Journal of Virology.
READ MORE...
Awarded in 2006 and completed in 2012, this project helped the MCW Cancer Center build a critical mass of cancer researchers collaborating to advance cancer treatment and prevention.
Awarded in 2009 and completed in 2011, this AHW project developed new animal models and technology to aid in innovative studies of human blinding diseases and the retina's rods and cones.
Funded by Research and Education in 2005 and led by Howard Jacob, PhD, the AHW project Genetic Analysis Initiative for Individualized Medicine developed the infrastructure necessary for individualized medicine by bringing DNA chip technology to MCW, generating preliminary data for grant applications, and identifying genes for several phenotypes.
Awarded in 2008 and completed in 2010, the AHW research project, The Role of Induced Regulatory T-Cells in Dominant Immunologic Tolerance, Calvin Williams, PhD, examined the mechanisms by which Regulatory T cells (Treg )control immune responses.
Awarded in 2007 and completed in 2010, this study applied new genomic approaches to combat diabetes in affected children and their siblings at-risk for developing the disease.
Awarded in 2009 and completed in 2011, this study identified a new gene that may be involved with Type 2 diabetes.
Awarded in January 2011 and led by Syed Ahmed, MD, MPH, DrPH, FAAFP, this AHW project is supporting meaningful and productive community engagement and training in clinical and translational research.
Awarded in 2009 and led by Christopher Butson, PhD, the AHW research project, Clinical Correlates of Deep Brain Stimulation, characterized neuropsychological outcomes in patients with Parkinson's disease (PD) who were receiving deep brain stimulation in the subthalamic nucleus.
Awarded in 2008 and completed in 2011, this study generated new knowledge on the role estrogen receptors play in the development of the most common pituitary gland tumors, called prolactinomas.
Awarded in 2009 and completed in 2012, this study used functional magnetic resonance imaging, or fMRI, to find differences in brain function in individuals with late-life depression and mild cognitive impairment.